ENT Support

Wirkstoff: SILVER NITRATE, ASPERGILLUS NIGER VAR. NIGER, CANDIDA ALBICANS, EUPHORBIA RESINIFERA RESIN, GALLIC ACID MONOHYDRATE, CALCIUM SULFIDE, INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE, INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE, LUFFA OPERCULATA FRUIT, MERCURIC IODIDE, MUCOR RACEMOSUS, ESCHERICHIA COLI, PULSATILLA PRATENSIS WHOLE, SINUSITISINUM

Flüssigkeit [Übersetzung der Form; Original: LIQUID (openFDA)] · SILVER NITRATE 10 [hp_X]/mL, ASPERGILLUS NIGER VAR. NIGER 10 [hp_C]/mL, CANDIDA ALBICANS 10 [hp_C]/mL, EUPHORBIA RESINIFERA RESIN 6 [hp_X]/mL, GALLIC ACID MONOHYDRATE 10 [hp_C]/mL, CALCIUM SULFIDE 10 [hp_X]/mL, INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 12 [hp_C]/mL, INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) 12 [hp_C]/mL, INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE 12 [hp_C]/mL, INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE 12 [hp_C]/mL, LUFFA OPERCULATA FRUIT 6 [hp_X]/mL, MERCURIC IODIDE 8 [hp_X]/mL, MUCOR RACEMOSUS 10 [hp_C]/mL, ESCHERICHIA COLI 30 [hp_C]/mL, PULSATILLA PRATENSIS WHOLE 4 [hp_X]/mL, SINUSITISINUM 17 [hp_X]/mL

Vereinigte Staaten·Aktiv

Zulassungsinhaber: Deseret Biologicals, Inc.

Geprüft 2026-10-09 · openFDA NDC